Kayode Ogungbenro

发表

Application of optimal design methodologies in clinical pharmacology experiments

Leon Aarons, Kayode Ogungbenro, Aristides Dokoumetzidis, 2009, Pharmaceutical statistics.

A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models

Gordon Graham, Leon Aarons, Kayode Ogungbenro, 2007, Comput. Methods Programs Biomed..

Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data

Leon Aarons, Kayode Ogungbenro, Thierry Wendling, 2015, The AAPS Journal.

Optimal design of pharmacokinetic studies.

Leon Aarons, Kayode Ogungbenro, L. Aarons, 2010, Basic & clinical pharmacology & toxicology.

The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments

Gordon Graham, Leon Aarons, Kayode Ogungbenro, 2005, Comput. Methods Programs Biomed..

Optimal Design for Multiresponse Pharmacokinetic–Pharmacodynamic Models – Dealing with Unbalanced Designs

Gordon Graham, Leon Aarons, Kayode Ogungbenro, 2007, Journal of Pharmacokinetics and Pharmacodynamics.

Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acid

Leon Aarons, Kayode Ogungbenro, 2011, Journal of Pharmacokinetics and Pharmacodynamics.

An Effective Approach for Obtaining Optimal Sampling Windows for Population Pharmacokinetic Experiments

Leon Aarons, Kayode Ogungbenro, L. Aarons, 2008, Journal of biopharmaceutical statistics.

Drug–drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial results

Leon Aarons, France Mentré, Kayode Ogungbenro, 2008, Journal of Pharmacokinetics and Pharmacodynamics.

Optimal Design for Drug-Drug Interaction Study Using PopDes - Application to SX and MDZ” and “PopDes - An Optimal Experimental Design Program for Individual and Population Uniresponse and Multiresponse PKPD models

Leon Aarons, Kayode Ogungbenro, Marylore Chenel, 2007 .

Software for optimal design in population pharmacokinetics and pharmacodynamics : a comparison

Andrew C. Hooker, Sergei Leonov, Sylvie Retout, 2007 .

Incorporating Correlation in Interindividual Variability for the Optimal Design of Multiresponse Pharmacokinetic Experiments

Leon Aarons, Kayode Ogungbenro, Ivelina Gueorguieva, 2008, Journal of biopharmaceutical statistics.

Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B‐Mediated Drug–Drug Interactions Using Population Pharmacokinetic Modeling and Simulation

Kayode Ogungbenro, Hong Shen, Shelby Barnett, 2018, Clinical pharmacology and therapeutics.

A Physiologically Based Pharmacokinetic Model for Clobazam and Stiripentol in Adults and Children

Leon Aarons, Kayode Ogungbenro, L. Aarons, 2014, Pharmaceutical Research.

The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors.

Munir Pirmohamed, Steven Lane, Leon Aarons, 2012, British journal of clinical pharmacology.

Optimisation of sampling windows design for population pharmacokinetic experiments

Leon Aarons, Kayode Ogungbenro, L. Aarons, 2008, Journal of Pharmacokinetics and Pharmacodynamics.

Model-Based Evaluation of the Impact of Formulation and Food Intake on the Complex Oral Absorption of Mavoglurant in Healthy Subjects

Leon Aarons, Kayode Ogungbenro, Thierry Wendling, 2014, Pharmaceutical Research.

Empirical and Semi-Mechanistic Modelling of Double-Peaked Pharmacokinetic Profile Phenomenon Due to Gastric Emptying

Leon Aarons, Kayode Ogungbenro, Henry Pertinez, 2014, The AAPS Journal.

Optimal Design for Multivariate Response Pharmacokinetic Models

Malcolm Rowland, Leon Aarons, Kayode Ogungbenro, 2006, Journal of Pharmacokinetics and Pharmacodynamics.

Drug–drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 1: comparison of uniresponse and multiresponse designs using PopDes

Leon Aarons, Kayode Ogungbenro, François Bouzom, 2008, Journal of Pharmacokinetics and Pharmacodynamics.

How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach

Leon Aarons, Kayode Ogungbenro, L. Aarons, 2008, European Journal of Clinical Pharmacology.

Sample Size Calculations for Population Pharmacodynamic Experiments Involving Repeated Dichotomous Observations

Leon Aarons, Kayode Ogungbenro, L. Aarons, 2007, Journal of biopharmaceutical statistics.

Sample Size Calculations Based on Generalized Estimating Equations for Population Pharmacokinetic Experiments

Leon Aarons, Kayode Ogungbenro, L. Aarons, 2006, Journal of biopharmaceutical statistics.

Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics

Leon Aarons, Kayode Ogungbenro, Thierry Wendling, 2015, Journal of Pharmacokinetics and Pharmacodynamics.

Optimal Blood Sampling Time Windows for Parameter Estimation Using a Population Approach: Design of a Phase II Clinical Trial

Leon Aarons, Kayode Ogungbenro, Marylore Chenel, 2005, Journal of Pharmacokinetics and Pharmacodynamics.